a, LLC and B16 tumours excised at day 19 and stained for F4/80 reveal a similar distribution pattern of macrophages at the periphery and within the centre of the tumours. b, Immunohistochemistry of B16 and LLC cells injected subcutaneously and harvested on day 19. Stains are for F4/80 (B16) and CD11b (LLC). c, d, The density of TAMs within tumours is conserved and depends on the tumour type. LLC (n = 10), B16 (n = 10) and CT26 (n = 5) tumours were harvested 19 days after subcutaneous injection. c, The percentage of macrophages that were F4/80⁺CD11b⁺ was determined by FACS analysis. (#, P = 0.0128; *P < 0.0001 using a two-tailed, unpaired t-test). The histograms represent the mean ± s.e.m. Whereas an F test revealed no significant difference in the variance between B16 and CT26, there was a significant difference (P = 0.0128) in the variance between B16 and LLC. Non-parametric analysis using the Mann–Whitney test revealed a significant difference in the percentage of macrophages between LLC and B16 tumours (P = 0.0007) and between CT26 and B16 tumours (P = 0.0007). d, FACS plot of B16 and LLC tumours harvested at day 19 after subcutaneous injection and stained for F4/80 and CD11b. e, Cytology of sorted peritoneal macrophages (PMΦ) and TAMs. The cytology is representative often different experiments.

a. Western blotting of HIF1α and actin on cells grown under conditions of normoxia (N; 20.0% O₂) or hypoxia (H; 0.1% O₂) or stimulated with control DMEM (C) or LLC-tumour-conditioned medium (LLC). b, c, Luciferase reporter assay of 293T cells transfected with a HIF1α oxygen-dependent domain–luciferase reporter (for protein stabilization) and a Vegf promoter–luciferase reporter (for gene expression). d, e, Expression analysis by qPCR of Hif1a I.1, Hif1a I.2, Pgc1a and Pgc1b mRNA in bone-marrow-derived macrophages stimulated with LLC tumour-conditioned medium, f–h, The active factor in tumour-conditioned medium is <3 kDa and is heat stable. Western blotting for ARG1 in bone-marrow-derived macrophages (f). Expression analysis by qPCR of Vegf mRNA in bone-marrow-derived macrophages (g). Expression analysis by qPCR of Vegf and Arg1 mRNA in bone-marrow-derived macrophages stimulated with boiled (100 °C) or non-boiled LLC tumour-conditioned medium (h). i, j, Adenosine and low pH do not induce the Vegf gene. Expression analysis by qPCR of Vegf mRNA in bone-marrow-derived macrophages stimulated as follows: control medium (DMEM), 50ng ml⁻¹ lipopolysaccharide (LPS) plus the adenosine agonist NECA (10 μM 5′-N-ethylcarboxamidoadenosine), LLC-tumour-conditioned medium, and boiled LLC tumour-conditioned medium, all ± 1 μM ZM241385 (an adenosine A_2A receptor inhibitor) (i); macrophage growth medium titrated to a range of pHs using sterile HCl (j). LLC-tumour-conditioned medium has a pH of 6.8. Where indicated, the relative expression histograms represent three biological replicates displayed as the mean ± s.e.m.

a, b, Expression analysis by qPCR of Pkm1 and Pkm2 mRNA in tissues from wild-type mice and from four tumour cell lines, normalized to Actb and Rpl13a as housekeeping genes. c, Expression analysis by qPCR of Pkm1 and Pkm2 mRNA in tissues from wild-type mice and from six tumour cell lines. qPCR results were normalized to the housekeeping gene Rpl13a. d, e, The in vivo intratumoral lactate levels in LLC and B16 tumours correspond to the concentrations that have been determined to activate macrophages in vitro. Lactate concentration (mM) in control (DMEM) or LLC-tumour-conditioned medium (unfractionated, <3-kDa fraction and >3-kDa fraction). Most of the lactic acid is present in the <3-kDa fraction (d). The mean in vivo lactic acid concentrations in LLC and B16 tumours were measured using hydrophilic interaction chromatography and mass spectroscopy (e). All relative expression histograms represent three biological replicates displayed as mean ± s.e.m. BAT, brown adipose tissue; WAT, white adipose tissue.

a, Expression analysis by qPCR of Vegf mRNA in bone-marrow-derived macrophages stimulated with LLC-tumour-conditioned medium at 0 h, 1 h, 6 h and 24 h. b, Expression analysis by qPCR of Arg1 mRNA in bone-marrow-derived macrophages cultured under normoxic conditions (20% O₂), hypoxic conditions (0.1% O₂) and with 25 mM lactic acid, at 6 h and 24 h. c, Time course of Vegf and Arg1 induction by lactic acid (25 mM), hypoxia (0.1% O₂) and lactic acid plus hypoxia in bone-marrow-derived macrophages. Expression analysis by qPCR of Vegf and Arg1 mRNA in wild-type (WT) or Hif1a knockout (KO) bone-marrow-derived macrophages at 0 h, 6 h, 24 h and 48 h. Where indicated, the relative expression histograms represent three biological replicates displayed as mean ± s.e.m.

Wild-type (WT) or Hif1a knockout (KO) peritoneal macrophages were plated in control medium (DMEM) or stimulated with lactic acid (25 mM) or hypoxia (0.1%) for 24 h.

a, Expression analysis by qPCR of bone-marrow-derived macrophages stimulated with unfractionated or fractionated (<3kDa and >3kDa) control or LLC-tumour-conditioned medium ±5 mM CHC (α-cyano-4-hydroxycinnamate), a monocarboxylate channel transporter inhibitor. b, Acidic pH is necessary for the effect of lactate on bone-marrow-derived macrophages. Expression analysis by qPCR of bone-marrow-derived macrophages stimulated for 6 h with lactic acid, calcium lactate, HCl plus calcium chloride, or HCl plus calcium lactate. c, Effect of lactic acid on LLC, B16 and CT26 tumour cells. Expression analysis by qPCR of LLC, B16 and CT26 tumour cells stimulated for 6h (Vegf, left) and 24h (Arg1, right). Where indicated, the relative expression histograms represent three biological replicates displayed as mean ± s.e.m.

Expression analysis by qPCR of FACS-sorted peritoneal macrophages and LLC TAMs. Results using either Rpl13a or Actb as a housekeeping gene are shown.

Expression analysis by qPCR of MHC II, Mrc1 and Cd11c mRNA from the following cell types: bone-marrow-derived macrophages stimulated with 25 mM lactic acid (a); TAMs from LLC tumours resected from mice with macrophages that are either wild-type (WT; C57BL/6J) or in which Hif1a has been deleted (b). Where indicated, the relative expression histograms represent three biological replicates displayed as mean ± s.e.m.

a, Lactic acid stimulation of bone-marrow-derived macrophages results in larger tumours when these macrophages are co-injected with LLC cells. The growth rate of LLC tumours in which LLC cells were co-injected 1:1 with bone-marrow-derived macrophages that had been stimulated for 24 h with either control DMEM (n = 15) or 25 mM lactic acid (n = 12) is shown. The tumour volumes were calculated using the formula (width)² × length × 0.52 (ref. 23); *P = 0.0305 on day 14; #P < 0.0001 on day 16, using a two-tailed, unpaired t-test. Whereas the F test revealed no significant difference in variance between the groups on day 14, there was a significant difference (P = 0.0477) in the variance between the groups on day 16. Non-parametric analysis using the Mann–Whitney test revealed a significant difference between the groups on both days 14 (P = 0.0240) and 16 (P = 0.0467). The data are presented as the mean volume ± s.e.m. b, TAMs oxidize more ¹⁴C-lactic acid to CO₂ than bone-marrow-derived macrophages and cultured LLC cells. TAMs, all other tumour cells (AO), bone-marrow-derived macrophages and LLC cells (1 × 10⁶) were cultured for 2 h in DMEM containing 100 μCi of ¹⁴C-laclic acid. c, d, Deletion of Arg1 in macrophages slows the growth of LLC and B16 tumours. c, The images are representative of LLC tumours from wild-type (WT) and Arg1 KO mice. d, The growth rate of B16 tumours in mice with WT (n = 9) versus Arg1 KO (n = 9) macrophages. The tumour volumes were calculated using the formula (width)² × length × 0.52 (ref. 23). The data are presented as the mean ± s.e.m. P < 0.05 on days 9 and 10 using a two-tailed, unpaired t-test. The F test revealed no significant difference in variance between the compared groups.

Expression analysis by qPCR of Cps1, Otc, Ass1, Asl, Arg1, Glul and Gpt mRNA in FACS-sorted TAMs and all other (AO) tumour cells from day 19 LLC tumours.

a, b, Expression analysis by quantitative PCR (qPCR) of Vegf and Arg1 mRNA in FACS-sorted peritoneal macrophages (PM), TAMs and all other cells (AO) within the tumour from day 19 LLC tumours. Expression is shown relative to the left histogram bar.

a, b, Expression analysis by qPCR of Vegf (a) and Arg1 (b) mRNA in bone-marrow-derived macrophages grown under conditions of normoxia (20% O₂) or hypoxia (0.1% O₂) (left panels) or stimulated with control medium (DMEM) or LLC-tumour-conditioned medium (right panels). c–f, Expression analysis by qPCR of Vegf (c, d) and Arg1 (e, f) mRNA in wild-type (WT) and Hif1a^−/− bone-marrow-derived macrophages stimulated with LLC-tumour-conditioned medium (d, f) or hypoxia (0.1% O₂) (c, e). The histogram bars represent the expression level of three biological replicates (relative to the left histogram bar), displayed as mean ± s.e.m. *P < 0.01, using a two-tailed, unpaired t-test. All experiments were performed at least twice.

a, b, Control (DMEM) or LLC-tumour-conditioned medium was used unfractionated (whole) or as <3-kDa or >3-kDa fractions to stimulate cells as follows. A luciferase reporter assay of 293T cells transfected with HIF1α oxygen-dependent domain (ODD)-luciferase was carried out to measure protein stabilization of the ODD; deferoxamine (DFO) was used as a hypoxia mimetic (a). Expression analysis by qPCR of Arg1 mRNA in bone-marrow-derived macrophages (b). c, Lactic acid concentration in the tumour-conditioned media from five tumour cell lines, collected after culturing at confluence for 4 days. d, Expression analysis by qPCR of Vegf mRNA in bone-marrow-derived macrophages stimulated with the tumour-conditioned media in c. e, f, Expression analysis by qPCR of Vegf (e) and Arg1 (f) mRNA in bone-marrow-derived macrophages cultured with a concentration gradient of lactic acid (LA). g, h, Expression analysis by qPCR of Vegf and Arg1 mRNA in wild-type (WT) and Hif1a^−/− bone-marrow-derived macrophages. b–h, The histogram bars represent the expression level of three biological replicates (relative to expression in DMEM), displayed as mean ± s.e.m. *P < 0.0001; **P < 0.001, using a two-tailed, unpaired t-test. All experiments were performed at least twice. NS, not significant; RLA, relative luciferase activity.

a–e, Expression analysis by qPCR of Arg1, Fizz1, Mgl1 and Mgl2 mRNA in the following cell types: TAMs and all other tumour cells (AO) from LLC tumours resected from wild-type (WT, C57BL/6J) mice (a), bone-marrow-derived macrophages stimulated with 25 mM lactic acid (LA) (b), TAMs and AO from LLC tumours resected from mice with either WT or Hif1a^−/− macrophages (c), WT or Hif1a^−/− bone-marrow-derived macrophages stimulated with control medium (DMEM) or IL-4 (10 ng ml⁻¹) (d), and TAMs and AO from CT26 colon carcinoma tumours resected from mice with WT (BALB/c) or Il4ra^−/− macrophages (e). f, Intratumoral lactic acid concentrations (mM) from tumours of LLC cells that had been stably transfected with a scrambled short hairpin RNA (shRNA) construct (SCR) or an shRNA targeting Pkm2 (centre panel). Expression analysis by qPCR of Arg1 mRNA in TAMs isolated from SCR-transfected and Pkm2-knockdown tumours. Weight of LLC tumours from cells bearing an SCR construct (mean ± s.e.m., 2.402 ± 0.310 g; n = 5) or Pkm2 shRNA construct (mean ± s.e.m, 0.8820 ± 0.341 g; n = 4); P = 0.0132 using a two-tailed, unpaired t-test (right panel). The F test revealed no significant difference in variance between the compared groups. g, Weight of LLC tumours resected on day 19 from mice with WT macrophages (mean ± s.e.m., 1.74 ± 0.161 g; n = 11) or ARG1-deficient macrophages (mean ± s.e.m., 0.965 ± 0.163 g; n = 13); P < 0.0028 using a two-tailed, unpaired t-test. The F test revealed no significant difference in variance between the compared groups. a–f, The histogram bars represent the expression level of three biological replicates, displayed as mean ± s.e.m., relative to AO (a, c, e, f) or DMEM (b, d). *P < 0.05; **P < 0.001, using a two-tailed, unpaired t-test. All experiments were performed at least twice. NS, not significant.